Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Check which passive funds beat the market in 2024 retirement planning and what factors contributed to their outperformance.
28,482 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Downtown office space faces renewed pressure as vacancies rise and tenants rethink their footprints. This article exp...
Strategy disclosed a program to sell bitcoin from time to time to support its USD reserve and finance stock repurchas...
A new DeFi bill in Congress could reshape who bears liability and how crypto markets are organized. This article brea...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...
A U.S. strike on Iran triggered a rapid reevaluation of crypto mining and Bitcoin hashrate resilience, with analysts ...
A $29 billion AI-linked stock offering goes live this week, setting up a crucial test of investor appetite for AI pla...
Major cryptocurrencies hold support as regulatory and macro headlines shape momentum. The crypto price prediction tod...
In a market fixated on the giants, Rezolve AI is flying under the radar as it grows ARR and eyes profitability in the...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
California's governor signs a bold policy to curb insider moves in prediction markets. The move, framed as protecting...
Poet Technologies sank today, sparking questions about its future. This analysis breaks down what happened, what it m...